Advance your academic career, collaborate globally, and expand your network— join now !

Thozhukat  Sathyapalan

Dr. Thozhukat Sathyapalan

Diabetes and Metabolism, Hull York Medical School, Academic Endocrinology, Hull ...

Share Link

Share

Information

Thozhukat Sathyapalan is a professor at the Hull York Medical School at the University of Hull. He obtained his undergraduate degree in Medicine from the University of Kerala, India, in 1996 and his MD (general medicine) from JIPMER, India. He subsequently completed his clinical training in Diabetes and Endocrinology as a Specialist Registrar in Yorkshire Deanery. Sathya was a Clinical Research Fellow at the University of Hull and obtained his MD (diabetes and endocrinology) in 2009. He was appointed as Senior Lecturer at Hull York Medical School in October 2009, Reader in 2012, and was made Chair in Academic Endocrinology and Metabolism in 2016. His main area of interest is the modulation of cardiovascular risk through pharmacological and nutritional interventions in insulin-resistant states, such as obesity, polycystic ovary syndrome (PCOS), and type 2 diabetes mellitus.

Research Keywords & Expertise

Diabetes
Insulin
Ovary
syndrome
Polycystic

Fingerprints

40%
Diabetes
32%
syndrome
29%
Insulin
27%
Polycystic
26%
Ovary

Short Biography

Thozhukat Sathyapalan is a professor at the Hull York Medical School at the University of Hull. He obtained his undergraduate degree in Medicine from the University of Kerala, India, in 1996 and his MD (general medicine) from JIPMER, India. He subsequently completed his clinical training in Diabetes and Endocrinology as a Specialist Registrar in Yorkshire Deanery. Sathya was a Clinical Research Fellow at the University of Hull and obtained his MD (diabetes and endocrinology) in 2009. He was appointed as Senior Lecturer at Hull York Medical School in October 2009, Reader in 2012, and was made Chair in Academic Endocrinology and Metabolism in 2016. His main area of interest is the modulation of cardiovascular risk through pharmacological and nutritional interventions in insulin-resistant states, such as obesity, polycystic ovary syndrome (PCOS), and type 2 diabetes mellitus.